Latest News
From the Journals
Experts call to revise the Uniform Determination of Death Act
A neurologist and her colleagues propose changes with the goal of clarifying and harmonizing procedures for determining death by neurologic...
From the Journals
QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolide
Adding lomustine to temozolomide did not decrease quality of life for patients, apart from clinically insignificant differences in mental function...
From the Journals
Data point to bidirectional link between sleep disorders and ADHD
Investigators found a dose-response relationship between sleep duration and the odds of having ADHD symptoms.
Feature
Vermont tops America’s Health Rankings for 2019
Mississippi wins/loses its annual battle for the bottom with Louisiana.
FDA/CDC
FDA okays first generics for Eliquis
“These approvals mark the first generic approvals of a direct oral anticoagulant.”
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
Feature
HealthCare.gov enrollment ends with unexpected extension
Trump administration brings stability to “what remains a failed experiment,” the CMS administrator said.
Feature
Appropriations bill, now law, eliminates ACA taxes, raises tobacco age
The appropriations bill includes a number of other health-related provisions, including increasing the minimum age for purchasing tobacco to 21....
News from the FDA/CDC
FDA approves Dayvigo for insomnia
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
Conference Coverage
First autoimmune epilepsy RCT supports IVIG therapy
BALTIMORE – Misdiagnosis and delayed treatment may mean that patients end up in nursing homes diagnosed with Alzheimer’s disease.
News
FDA warns gabapentin, pregabalin may cause serious breathing problems
The drugs increase the risk of respiratory depression when used with central nervous system depressants or in patients with lung problems,...